0
     

Report Added
Report already added
PD-L1 Biomarker Testing Market - Global Outlook and Forecast 2021-2027

PD-L1 Biomarker Testing Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of PD-L1 Biomarker Testing in Global, including the following market information:
Global PD-L1 Biomarker Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global PD-L1 Biomarker Testing market was valued at 1052.2 million in 2020 and is projected to reach US$ 3710.5 million by 2027, at a CAGR of 37.0% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-L1 Biomarker Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-L1 Biomarker Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global PD-L1 Biomarker Testing Market Segment Percentages, By Type, 2020 (%)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other

China PD-L1 Biomarker Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China PD-L1 Biomarker Testing Market Segment Percentages, By Application, 2020 (%)
Hospital
Diagnostic Center
Others

Global PD-L1 Biomarker Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global PD-L1 Biomarker Testing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total PD-L1 Biomarker Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total PD-L1 Biomarker Testing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
1 Introduction to Research & Analysis Reports
1.1 PD-L1 Biomarker Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-L1 Biomarker Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global PD-L1 Biomarker Testing Overall Market Size
2.1 Global PD-L1 Biomarker Testing Market Size: 2021 VS 2027
2.2 Global PD-L1 Biomarker Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top PD-L1 Biomarker Testing Players in Global Market
3.2 Top Global PD-L1 Biomarker Testing Companies Ranked by Revenue
3.3 Global PD-L1 Biomarker Testing Revenue by Companies
3.4 Top 3 and Top 5 PD-L1 Biomarker Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies PD-L1 Biomarker Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 PD-L1 Biomarker Testing Players in Global Market
3.6.1 List of Global Tier 1 PD-L1 Biomarker Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 PD-L1 Biomarker Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global PD-L1 Biomarker Testing Market Size Markets, 2021 & 2027
4.1.2 PD-L1 (22C3)
4.1.3 PD-L1(28-8)
4.1.4 PD-L1 (SP142)
4.1.5 PD-L1 (SP263)
4.1.6 Other
4.2 By Type - Global PD-L1 Biomarker Testing Revenue & Forecasts
4.2.1 By Type - Global PD-L1 Biomarker Testing Revenue, 2016-2021
4.2.2 By Type - Global PD-L1 Biomarker Testing Revenue, 2022-2027
4.2.3 By Type - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global PD-L1 Biomarker Testing Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Diagnostic Center
5.1.4 Others
5.2 By Application - Global PD-L1 Biomarker Testing Revenue & Forecasts
5.2.1 By Application - Global PD-L1 Biomarker Testing Revenue, 2016-2021
5.2.2 By Application - Global PD-L1 Biomarker Testing Revenue, 2022-2027
5.2.3 By Application - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global PD-L1 Biomarker Testing Market Size, 2021 & 2027
6.2 By Region - Global PD-L1 Biomarker Testing Revenue & Forecasts
6.2.1 By Region - Global PD-L1 Biomarker Testing Revenue, 2016-2021
6.2.2 By Region - Global PD-L1 Biomarker Testing Revenue, 2022-2027
6.2.3 By Region - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America PD-L1 Biomarker Testing Revenue, 2016-2027
6.3.2 US PD-L1 Biomarker Testing Market Size, 2016-2027
6.3.3 Canada PD-L1 Biomarker Testing Market Size, 2016-2027
6.3.4 Mexico PD-L1 Biomarker Testing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe PD-L1 Biomarker Testing Revenue, 2016-2027
6.4.2 Germany PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.3 France PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.4 U.K. PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.5 Italy PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.6 Russia PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.7 Nordic Countries PD-L1 Biomarker Testing Market Size, 2016-2027
6.4.8 Benelux PD-L1 Biomarker Testing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia PD-L1 Biomarker Testing Revenue, 2016-2027
6.5.2 China PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.3 Japan PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.4 South Korea PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.5 Southeast Asia PD-L1 Biomarker Testing Market Size, 2016-2027
6.5.6 India PD-L1 Biomarker Testing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America PD-L1 Biomarker Testing Revenue, 2016-2027
6.6.2 Brazil PD-L1 Biomarker Testing Market Size, 2016-2027
6.6.3 Argentina PD-L1 Biomarker Testing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa PD-L1 Biomarker Testing Revenue, 2016-2027
6.7.2 Turkey PD-L1 Biomarker Testing Market Size, 2016-2027
6.7.3 Israel PD-L1 Biomarker Testing Market Size, 2016-2027
6.7.4 Saudi Arabia PD-L1 Biomarker Testing Market Size, 2016-2027
6.7.5 UAE PD-L1 Biomarker Testing Market Size, 2016-2027
7 Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Corporate Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies PD-L1 Biomarker Testing Major Product Offerings
7.1.4 Agilent Technologies PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.1.5 Agilent Technologies Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche PD-L1 Biomarker Testing Major Product Offerings
7.2.4 Roche PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck PD-L1 Biomarker Testing Major Product Offerings
7.3.4 Merck PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.3.5 Merck Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Major Product Offerings
7.4.4 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.4.5 Bristol-Myers Squibb Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca PD-L1 Biomarker Testing Major Product Offerings
7.5.4 AstraZeneca PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.5.5 AstraZeneca Key News
7.6 Ono Pharmaceutical
7.6.1 Ono Pharmaceutical Corporate Summary
7.6.2 Ono Pharmaceutical Business Overview
7.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Major Product Offerings
7.6.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.6.5 Ono Pharmaceutical Key News
7.7 Regeneron
7.7.1 Regeneron Corporate Summary
7.7.2 Regeneron Business Overview
7.7.3 Regeneron PD-L1 Biomarker Testing Major Product Offerings
7.4.4 Regeneron PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.7.5 Regeneron Key News
7.8 Innovent
7.8.1 Innovent Corporate Summary
7.8.2 Innovent Business Overview
7.8.3 Innovent PD-L1 Biomarker Testing Major Product Offerings
7.8.4 Innovent PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.8.5 Innovent Key News
7.9 Hengrui Medicine
7.9.1 Hengrui Medicine Corporate Summary
7.9.2 Hengrui Medicine Business Overview
7.9.3 Hengrui Medicine PD-L1 Biomarker Testing Major Product Offerings
7.9.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.9.5 Hengrui Medicine Key News
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Corporate Summary
7.10.2 Junshi Biosciences Business Overview
7.10.3 Junshi Biosciences PD-L1 Biomarker Testing Major Product Offerings
7.10.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue in Global (2016-2021)
7.10.5 Junshi Biosciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. PD-L1 Biomarker Testing Market Opportunities & Trends in Global Market
Table 2. PD-L1 Biomarker Testing Market Drivers in Global Market
Table 3. PD-L1 Biomarker Testing Market Restraints in Global Market
Table 4. Key Players of PD-L1 Biomarker Testing in Global Market
Table 5. Top PD-L1 Biomarker Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global PD-L1 Biomarker Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global PD-L1 Biomarker Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies PD-L1 Biomarker Testing Product Type
Table 9. List of Global Tier 1 PD-L1 Biomarker Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PD-L1 Biomarker Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global PD-L1 Biomarker Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - PD-L1 Biomarker Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - PD-L1 Biomarker Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global PD-L1 Biomarker Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - PD-L1 Biomarker Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - PD-L1 Biomarker Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global PD-L1 Biomarker Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global PD-L1 Biomarker Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global PD-L1 Biomarker Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America PD-L1 Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe PD-L1 Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia PD-L1 Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America PD-L1 Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa PD-L1 Biomarker Testing Revenue, (US$, Mn), 2022-2027
Table 30. Agilent Technologies Corporate Summary
Table 31. Agilent Technologies PD-L1 Biomarker Testing Product Offerings
Table 32. Agilent Technologies PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 33. Roche Corporate Summary
Table 34. Roche PD-L1 Biomarker Testing Product Offerings
Table 35. Roche PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 36. Merck Corporate Summary
Table 37. Merck PD-L1 Biomarker Testing Product Offerings
Table 38. Merck PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Offerings
Table 41. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca PD-L1 Biomarker Testing Product Offerings
Table 44. AstraZeneca PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 45. Ono Pharmaceutical Corporate Summary
Table 46. Ono Pharmaceutical PD-L1 Biomarker Testing Product Offerings
Table 47. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 48. Regeneron Corporate Summary
Table 49. Regeneron PD-L1 Biomarker Testing Product Offerings
Table 50. Regeneron PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 51. Innovent Corporate Summary
Table 52. Innovent PD-L1 Biomarker Testing Product Offerings
Table 53. Innovent PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 54. Hengrui Medicine Corporate Summary
Table 55. Hengrui Medicine PD-L1 Biomarker Testing Product Offerings
Table 56. Hengrui Medicine PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)
Table 57. Junshi Biosciences Corporate Summary
Table 58. Junshi Biosciences PD-L1 Biomarker Testing Product Offerings
Table 59. Junshi Biosciences PD-L1 Biomarker Testing Revenue (US$, Mn), (2016-2021)

List of Figures
Figure 1. PD-L1 Biomarker Testing Segment by Type
Figure 2. PD-L1 Biomarker Testing Segment by Application
Figure 3. Global PD-L1 Biomarker Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global PD-L1 Biomarker Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global PD-L1 Biomarker Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2020
Figure 8. By Type - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 12. US PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 16. Germany PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 24. China PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 30. Brazil PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa PD-L1 Biomarker Testing Revenue Market Share, 2016-2027
Figure 33. Turkey PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE PD-L1 Biomarker Testing Revenue, (US$, Mn), 2016-2027
Figure 37. Agilent Technologies PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Roche PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merck PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Regeneron PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Innovent PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Hengrui Medicine PD-L1 Biomarker Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Report Title: PD-L1 Biomarker Testing Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW